[HTML][HTML] ctDNA and adjuvant therapy for colorectal cancer: time to re-invent our treatment paradigm
M Naidoo, P Gibbs, J Tie - Cancers, 2021 - mdpi.com
Simple Summary There is currently a lack of useful tests to detect microscopic residual
disease in patients who have undergone surgery to remove their bowel cancer. This inability …
disease in patients who have undergone surgery to remove their bowel cancer. This inability …
ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
M Naidoo, P Gibbs, J Tie - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
While there have been significant developments in the treatments for patients with metastatic …
While there have been significant developments in the treatments for patients with metastatic …
ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm.
M Naidoo, P Gibbs, J Tie - Cancers, 2021 - europepmc.org
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
While there have been significant developments in the treatments for patients with metastatic …
While there have been significant developments in the treatments for patients with metastatic …
[PDF][PDF] Tie, J. ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
M Naidoo, P Gibbs - variations, 2017 - minerva-access.unimelb.edu.au
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
While there have been significant developments in the treatments for patients with metastatic …
While there have been significant developments in the treatments for patients with metastatic …
[HTML][HTML] ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
M Naidoo, P Gibbs, J Tie - Cancers, 2021 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
While there have been significant developments in the treatments for patients with metastatic …
While there have been significant developments in the treatments for patients with metastatic …
[PDF][PDF] Tie, J. ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
M Naidoo, P Gibbs - variations, 2017 - pdfs.semanticscholar.org
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
While there have been significant developments in the treatments for patients with metastatic …
While there have been significant developments in the treatments for patients with metastatic …
ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm.
M Naidoo, P Gibbs, J Tie - Cancers, 2021 - search.ebscohost.com
Abstract Simple Summary: There is currently a lack of useful tests to detect microscopic
residual disease in patients who have undergone surgery to remove their bowel cancer …
residual disease in patients who have undergone surgery to remove their bowel cancer …
Tie, J. ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
M Naidoo, P Gibbs - variations, 2017 - search.proquest.com
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
While there have been significant developments in the treatments for patients with metastatic …
While there have been significant developments in the treatments for patients with metastatic …